- Home
- WAVE vs FGEN Comparison
WAVE vs FGEN Comparison
Compare WAVE & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- FGEN
- Stock Information
- Founded
- WAVE 2011
- FGEN 1993
- Country
- WAVE Israel
- FGEN United States
- Employees
- WAVE N/A
- FGEN N/A
- Industry
- WAVE Electric Utilities: Central
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- FGEN Health Care
- Exchange
- WAVE Nasdaq
- FGEN Nasdaq
- Market Cap
- WAVE 34.2M
- FGEN 33.5M
- IPO Year
- WAVE 2021
- FGEN 2014
- Fundamental
- Price
- WAVE $5.71
- FGEN $5.30
- Analyst Decision
- WAVE Strong Buy
- FGEN Strong Buy
- Analyst Count
- WAVE 1
- FGEN 1
- Target Price
- WAVE $15.00
- FGEN $250.00
- AVG Volume (30 Days)
- WAVE 17.1K
- FGEN 52.1K
- Earning Date
- WAVE 05-08-2025
- FGEN 08-05-2025
- Dividend Yield
- WAVE N/A
- FGEN N/A
- EPS Growth
- WAVE N/A
- FGEN N/A
- EPS
- WAVE N/A
- FGEN N/A
- Revenue
- WAVE $168,000.00
- FGEN $6,996,000.00
- Revenue This Year
- WAVE $325.00
- FGEN N/A
- Revenue Next Year
- WAVE $85.71
- FGEN N/A
- P/E Ratio
- WAVE N/A
- FGEN N/A
- Revenue Growth
- WAVE N/A
- FGEN N/A
- 52 Week Low
- WAVE $2.37
- FGEN $4.50
- 52 Week High
- WAVE $17.63
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- WAVE 48.66
- FGEN 35.87
- Support Level
- WAVE $4.41
- FGEN $5.22
- Resistance Level
- WAVE $6.00
- FGEN $5.85
- Average True Range (ATR)
- WAVE 0.43
- FGEN 0.56
- MACD
- WAVE 0.01
- FGEN -0.15
- Stochastic Oscillator
- WAVE 72.70
- FGEN 19.90
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.